Iqvia Holdings Inc stock is traded at $265.12, with a volume of 1,976,812. It is down -2.21% in the last 24 hours and up +1.70% over the past month. Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Previous Close:
$271.11
Open:
$271.72
24h Volume:
1,976,812
Relative Volume:
1.41
Market Cap:
$43.69B
Revenue:
$16.63B
Net Income/Loss:
$1.39B
P/E Ratio:
32.86
EPS:
$8.07
Net Cash Flow:
$2.12B
1W Performance:
-2.47%
1M Performance:
+1.70%
6M Performance:
+53.80%
1Y Performance:
+18.60%
1-Day Range:
$263.50$272.12
1-Week Range:
$263.50$281.24
52-Week Range:
$154.50$284.50
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
919-998-2000Address
2400 ELLIS ROAD, DURHAM, NC, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS